Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 10:29AM ET
0.9899
Dollar change
+0.0624
Percentage change
6.73
%
Index- P/E- EPS (ttm)-6.12 Insider Own39.92% Shs Outstand20.27M Perf Week4.20%
Market Cap20.07M Forward P/E- EPS next Y-1.94 Insider Trans-0.04% Shs Float12.18M Perf Month-29.29%
Income-63.23M PEG- EPS next Q-0.75 Inst Own11.88% Short Float2.85% Perf Quarter-76.98%
Sales12.00M P/S1.67 EPS this Y23.62% Inst Trans- Short Ratio2.88 Perf Half Y-85.80%
Book/sh-2.42 P/B- EPS next Y59.79% ROA-109.80% Short Interest0.35M Perf Year-80.59%
Cash/sh1.04 P/C0.95 EPS next 5Y30.00% ROE- 52W Range0.83 - 11.90 Perf YTD-74.75%
Dividend Est.- P/FCF- EPS past 5Y8.41% ROI- 52W High-91.68% Beta0.51
Dividend TTM- Quick Ratio0.76 Sales past 5Y24.45% Gross Margin32.84% 52W Low18.91% ATR (14)0.17
Dividend Ex-Date- Current Ratio0.86 EPS Y/Y TTM37.22% Oper. Margin-476.98% RSI (14)27.93 Volatility18.71% 12.76%
Employees179 Debt/Eq- Sales Y/Y TTM-8.52% Profit Margin-526.73% Recom2.00 Target Price2.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q103.42% Payout- Rel Volume0.12 Prev Close0.93
Sales Surprise-6.64% EPS Surprise117.22% Sales Q/Q11.45% EarningsNov 09 AMC Avg Volume120.59K Price0.99
SMA20-12.77% SMA50-57.98% SMA200-81.76% Trades Volume3,076 Change6.73%
Date Action Analyst Rating Change Price Target Change
Mar-09-22Downgrade Craig Hallum Buy → Hold $5
Oct-08-20Initiated BTIG Research Neutral
Aug-07-20Upgrade Craig Hallum Hold → Buy $20
Sep-27-19Downgrade JP Morgan Neutral → Underweight $16
Nov-07-18Downgrade JP Morgan Overweight → Neutral
May-24-18Initiated Craig Hallum Hold $25
Dec-13-17Downgrade BTIG Research Buy → Neutral
Jul-12-17Resumed BTIG Research Buy $34
Mar-24-16Initiated JP Morgan Overweight $17
Dec-16-15Initiated Piper Jaffray Overweight
Jan-19-24 09:20AM
Jan-16-24 07:45AM
Jan-07-24 08:00PM
Nov-29-23 08:43AM
Nov-27-23 09:15AM
09:35AM Loading…
Nov-22-23 09:35AM
Nov-11-23 10:44AM
Nov-09-23 06:42PM
04:05PM
Oct-30-23 09:30AM
Oct-03-23 08:50AM
Sep-14-23 11:01PM
Aug-11-23 05:59AM
Aug-10-23 05:30PM
04:26PM
04:05PM Loading…
04:05PM
Jul-27-23 09:30AM
Jul-10-23 09:00AM
Jun-29-23 09:40AM
Jun-13-23 09:40AM
09:00AM
07:03AM
May-23-23 09:40AM
May-12-23 09:53AM
May-11-23 05:25PM
04:20PM
04:05PM
09:09AM
May-10-23 11:18AM
10:23AM
09:23AM Loading…
09:23AM
Apr-27-23 09:30AM
Apr-19-23 08:38AM
Apr-17-23 06:38AM
Apr-03-23 12:00PM
Apr-01-23 12:47PM
Mar-29-23 05:25PM
04:05PM
Mar-15-23 09:30AM
Mar-14-23 08:00PM
Mar-08-23 08:30AM
Feb-06-23 05:23AM
Dec-19-22 01:32PM
Nov-16-22 10:22AM
Nov-14-22 04:05PM
Oct-24-22 01:52PM
10:02AM
Oct-19-22 01:27PM
Aug-23-22 08:02AM
Aug-19-22 04:50PM
Aug-18-22 09:30PM
09:28AM
Aug-17-22 06:00PM
Aug-15-22 02:41PM
08:15AM
06:50AM
Jul-28-22 07:09AM
Jul-25-22 09:30AM
Jul-11-22 08:00AM
Jun-13-22 06:55AM
May-23-22 09:30AM
May-16-22 06:15PM
04:05PM
08:06AM
May-12-22 06:25PM
May-10-22 05:55PM
May-05-22 09:00AM
May-04-22 08:25AM
Apr-29-22 09:30AM
Apr-25-22 08:41AM
Mar-28-22 08:05AM
Mar-15-22 06:15AM
Mar-08-22 05:45PM
04:05PM
Feb-24-22 09:30AM
Feb-15-22 03:01PM
Feb-10-22 05:55PM
Feb-02-22 09:30AM
Jan-31-22 05:05AM
Jan-28-22 09:38AM
Jan-13-22 09:15AM
Jan-12-22 09:15AM
Dec-29-21 09:30AM
Dec-01-21 04:07AM
Nov-27-21 06:35AM
Nov-22-21 07:00AM
Nov-09-21 06:55PM
04:05PM
Nov-02-21 03:01PM
Oct-21-21 08:07AM
Oct-19-21 08:00AM
Sep-30-21 08:36PM
Sep-29-21 08:31AM
Sep-28-21 06:29AM
Sep-23-21 09:15AM
Aug-05-21 08:35PM
04:05PM
Aug-03-21 08:00AM
Jul-30-21 10:28AM
Jul-29-21 03:05PM
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patience DavidChief Financial OfficerFeb 26Option Exercise0.001,000026,597Feb 27 06:59 PM
Patience DavidChief Financial OfficerFeb 26Sale0.9635033626,247Feb 27 06:59 PM
Phillips JackChief Executive OfficerFeb 01Option Exercise0.001,000077,201Feb 02 04:48 PM
Phillips JackChief Executive OfficerFeb 01Sale1.3049464276,707Feb 02 04:48 PM
Phillips JackChief Executive OfficerDec 13Option Exercise0.001,721060,274Dec 14 05:15 PM
Patience DavidChief Financial OfficerDec 13Option Exercise0.0033109,028Dec 14 05:14 PM
Phillips JackChief Executive OfficerDec 13Sale4.397393,24459,535Dec 14 05:15 PM
Patience DavidChief Financial OfficerDec 13Sale4.39974268,931Dec 14 05:14 PM
Phillips JackChief Executive OfficerOct 13Option Exercise0.001,721058,310Oct 16 05:16 PM
Patience DavidChief Financial OfficerOct 13Option Exercise0.0033108,559Oct 16 05:17 PM
Phillips JackChief Executive OfficerOct 13Sale5.837344,27957,576Oct 16 05:16 PM
Patience DavidChief Financial OfficerOct 13Sale5.83965608,463Oct 16 05:17 PM
Patience DavidChief Financial OfficerSep 13Option Exercise0.0033108,324Sep 14 04:11 PM
Phillips JackChief Executive OfficerSep 13Option Exercise0.001,722057,322Sep 14 04:13 PM
Phillips JackChief Executive OfficerSep 13Sale6.537334,78656,589Sep 14 04:13 PM
Patience DavidChief Financial OfficerSep 13Sale6.53966278,228Sep 14 04:11 PM
Phillips JackChief Executive OfficerAug 14Sale6.807515,10755,600Aug 15 07:22 PM
Patience DavidChief Financial OfficerAug 14Sale6.80956467,993Aug 15 07:22 PM
Phillips JackChief Executive OfficerAug 13Option Exercise0.001,722056,351Aug 15 07:22 PM
Patience DavidChief Financial OfficerAug 13Option Exercise0.0033108,088Aug 15 07:22 PM
Phillips JackChief Executive OfficerJul 13Option Exercise0.001,722055,358Jul 17 05:11 PM
Patience DavidChief Financial OfficerJul 13Option Exercise0.0033007,849Jul 17 05:20 PM
Phillips JackChief Executive OfficerJul 13Sale6.907295,03054,629Jul 17 05:11 PM
Patience DavidChief Financial OfficerJul 13Sale6.90926357,757Jul 17 05:20 PM
Phillips JackChief Executive OfficerJun 22Option Exercise0.0062,1600563,624Jun 26 06:48 PM
Phillips JackChief Executive OfficerJun 22Sale0.7127,26219,356536,362Jun 26 06:48 PM
Phillips JackChief Executive OfficerJun 13Option Exercise0.0017,2160509,854Jun 15 01:18 PM
Patience DavidChief Financial OfficerJun 13Option Exercise0.003,309076,479Jun 15 01:19 PM
Phillips JackChief Executive OfficerJun 13Sale0.908,3907,551501,464Jun 15 01:18 PM
Patience DavidChief Financial OfficerJun 13Sale0.901,2871,15875,192Jun 15 01:19 PM
FRANCESCONI LOUISEDirectorMay 31Option Exercise0.0075,949075,949Jun 01 08:31 PM
MASSARANY HANYDirectorMay 31Option Exercise0.0075,949075,949Jun 01 08:30 PM
SCHULER JACK WDirectorMay 31Option Exercise0.0075,949075,949Jun 01 08:29 PM
BURRIS WAYNEDirectorMay 31Option Exercise0.008,39208,392Jun 01 08:26 PM
Mertz Larry MichaelChief Technology OfficerMay 22Option Exercise0.0012,8360526,464May 24 08:03 PM
Mertz Larry MichaelChief Technology OfficerMay 22Sale0.723,4802,506523,628May 24 08:03 PM
Brown Thomas DDirectorMay 19Option Exercise0.0069,6190116,160May 26 06:03 PM
Watts Charles MDirectorMay 19Option Exercise0.0069,619069,619May 26 05:55 PM
Patience DavidChief Financial OfficerMay 15Option Exercise0.003,309074,392May 16 05:38 PM
Phillips JackChief Executive OfficerMay 15Option Exercise0.0017,2170500,578May 16 05:38 PM
Phillips JackChief Executive OfficerMay 15Sale0.697,9405,479492,638May 16 05:38 PM
Patience DavidChief Financial OfficerMay 15Sale0.691,22284373,170May 16 05:38 PM
Phillips JackChief Executive OfficerApr 13Option Exercise0.0017,2160490,805Apr 17 09:51 PM
Patience DavidChief Financial OfficerApr 13Option Exercise0.003,309072,230Apr 17 09:54 PM
Phillips JackChief Executive OfficerApr 13Sale0.657,4444,839483,361Apr 17 09:51 PM
Patience DavidChief Financial OfficerApr 13Sale0.651,14774671,083Apr 17 09:54 PM
REICHLING STEVENChief Financial OfficerMar 13Option Exercise0.009,4380147,078Mar 15 02:15 PM
Phillips JackChief Executive OfficerMar 13Option Exercise0.0017,2170481,040Mar 15 02:15 PM
Phillips JackChief Executive OfficerMar 13Sale0.497,4513,651473,589Mar 15 02:15 PM
REICHLING STEVENChief Financial OfficerMar 13Sale0.494,7082,307142,370Mar 15 02:15 PM
REICHLING STEVENChief Financial OfficerMar 08Option Exercise0.00123,6000200,418Mar 13 05:46 PM
Phillips JackChief Executive OfficerMar 08Option Exercise0.00350,0000619,458Mar 13 05:46 PM
Phillips JackChief Executive OfficerMar 08Sale0.47155,63573,148463,823Mar 13 05:46 PM
REICHLING STEVENChief Financial OfficerMar 08Sale0.4762,77829,506137,640Mar 13 05:46 PM
MILLER MARK CDirectorMar 07Option Exercise0.0055,282055,282Mar 09 04:24 PM
TEN BRINK FRANK JMDirectorMar 03Option Exercise0.0050,886060,686Mar 06 07:41 PM
Mertz Larry MichaelChief Technology OfficerMar 02Option Exercise0.00116,3290549,740Mar 06 07:41 PM
Mertz Larry MichaelChief Technology OfficerMar 02Sale0.4933,40116,366516,339Mar 06 07:41 PM